Steven Klosk
Fortune : 212 663 $ au 31/05/2026
Fortune : 212 663 $ au 31/05/2026
Steven M.
Klosk is currently Chairman at Formulated Solutions LLC since 2021.
He serves as Director at St. Joseph's Hospital Foundation (Georgia), BioIVT LLC since 2021, NPS, Inc. (GA), and Lisata Therapeutics, Inc. since 2014.
Formerly, Mr. Klosk was Chief Executive Officer & Director at Cambrex Corp.
in 2020.
He was Director at Recipharm AB, BioVectra, Inc., and NJ Bio, Inc. from 2021 to 2024.
He served as Director at Bolt Projects Holdings, Inc. from 2024 to 2025.
He held the position of Secretary & Vice President-Administration at The Genlyte Group, Inc. from 1988 to 1992 and Vice President-Administration at Lightolier, Inc. from 1985 to 1988.
Mr. Klosk attended Cornell University for undergraduate studies and New York Law School for graduate studies.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/01/2026 | 65 359 ( 0,72 % ) | 212 417 $ | 31/05/2026 | |
0,08 % | 25/11/2024 | 3 625 ( 0,08 % ) | 247 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| LISATA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/01/2014 |
St. Joseph's Hospital Foundation (Georgia) | Directeur/Membre du Conseil | 13/04/2009 |
NPS, Inc. (GA) | Directeur/Membre du Conseil | - |
BioIVT LLC
BioIVT LLC Medical/Nursing ServicesHealth Services Provides bio specimen and research services to the life science & diagnostic industries | Directeur/Membre du Conseil | 01/10/2021 |
Formulated Solutions LLC
Formulated Solutions LLC Medical SpecialtiesHealth Technology Manufactures medical devices | Président | 01/09/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
NJ Bio, Inc
NJ Bio, Inc BiotechnologyHealth Technology Provides integrated chemistry and biology services | Directeur/Membre du Conseil | 01/12/2024 |
BioVectra, Inc.
BioVectra, Inc. BiotechnologyHealth Technology Operates as a contract development and manufacturing organization that specializes in clinical-to-commercial scale production for biologics, small molecules, bioreagents and lipids | Directeur/Membre du Conseil | 01/09/2024 |
| RECIPHARM AB (PUBL) | Directeur/Membre du Conseil | 01/04/2024 |
| CAMBREX CORPORATION | Directeur Général | 30/06/2020 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 15 |
|---|---|
Cambrex Corp.
Cambrex Corp. Pharmaceuticals: GenericHealth Technology Develops and manufactures drug substances | Health Technology |
The Genlyte Group, Inc.
The Genlyte Group, Inc. Electrical ProductsProducer Manufacturing Produces lighting fixtures and controls | Producer Manufacturing |
Recipharm AB
Recipharm AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical contract development and manufacturing organization | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lightolier, Inc.
Lightolier, Inc. Electrical ProductsProducer Manufacturing Manufactures luminaires | Producer Manufacturing |
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes cellular therapies products | Health Technology |
St. Joseph's Hospital Foundation (Georgia) | |
New York Law School
New York Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioVectra, Inc.
BioVectra, Inc. BiotechnologyHealth Technology Operates as a contract development and manufacturing organization that specializes in clinical-to-commercial scale production for biologics, small molecules, bioreagents and lipids | Health Technology |
BioIVT LLC
BioIVT LLC Medical/Nursing ServicesHealth Services Provides bio specimen and research services to the life science & diagnostic industries | Health Services |
Formulated Solutions LLC
Formulated Solutions LLC Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
NPS, Inc. (GA) | |
Golden Arrow Merger Corp.
Golden Arrow Merger Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
NJ Bio, Inc
NJ Bio, Inc BiotechnologyHealth Technology Provides integrated chemistry and biology services | Health Technology |
Lisata Therapeutics, Inc.
Lisata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national